XML 39 R22.htm IDEA: XBRL DOCUMENT v3.22.4
STOCK-BASED COMPENSATION
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
STOCK-BASED COMPENSATION STOCK-BASED COMPENSATIONThe following costs related to the Company’s stock compensation plans were included in the consolidated statements of income:
For the Years Ended December 31,
202220212020
Cost of revenues (exclusive of depreciation and amortization)$47,470 $51,580 $32,785 
Selling, general and administrative expenses
52,439 60,075 42,453 
Total$99,909 $111,655 $75,238 
Equity Plans
The Company has long-term incentive plans under which 3.564 million shares of common stock are available for issuance to Company personnel and 517 thousand shares of common stock are available for issuance to non-employee directors as of December 31, 2022. All of the awards issued pursuant to the long-term incentive plans expire 10 years from the date of grant.
In addition, the Company maintains an Employee Stock Purchase Plan (“ESPP”) to enable eligible employees to purchase shares of EPAM’s common stock at a discount through payroll deductions of up to 10% of their eligible compensation at the end of each designated offering period, which occurs every six months in April and November. The purchase price is equal to 85% of the fair market value of a share of EPAM’s common stock on the first date of an offering or the date of purchase, whichever is lower. As of December 31, 2022, 780 thousand shares of common stock remained available for issuance under the ESPP.
Stock Options
Stock option activity under the Company’s long-term incentive plans is set forth below:
 Number of
Options
Weighted Average
Exercise Price 
Aggregate
Intrinsic Value 
Weighted Average
Remaining Contractual Term (in years)
Options outstanding as of January 1, 20203,323 $50.85 $536,015 
Options granted158 $187.76 
Options exercised(700)$37.79 
Options forfeited(9)$119.30 
Options outstanding as of December 31, 20202,772 $61.71 $822,152 
Options granted94 $410.03 
Options exercised(536)$49.13 
Options forfeited(12)$248.74 
Options outstanding as of December 31, 20212,318 $77.79 $1,369,132 
Options granted133 $277.85 
Options exercised(514)$44.02 
Options forfeited(11)$350.19 
Options expired(3)$128.11 
Options outstanding as of December 31, 20221,923 $98.92 $447,503 3.4
Options vested and exercisable as of December 31, 20221,627 $67.51 $425,184 2.6
Options expected to vest as of December 31, 2022279 $270.39 $21,357 8.2
The fair value of each option award is estimated on the date of grant using the Black-Scholes option valuation model. The model incorporated the following weighted average assumptions:
For the Years Ended December 31,
202220212020
Expected volatility46.7 %35.3 %36.9 %
Expected term (in years)6.246.246.25
Risk-free interest rate2.6 %1.2 %0.5 %
Expected dividends— %— %— %
Expected volatility is based on the historical volatility of the Company’s stock price. The expected term represents the period of time that options granted are expected to be outstanding. The risk-free rate is based on the U.S. Treasury yield curve for the periods equal to the expected term of the options in effect at the time of grant. The Company has not declared or paid any dividends on its common stock and does not anticipate paying any dividends in the foreseeable future.
The weighted average grant-date fair value of stock options granted during the years ended December 31, 2022, 2021 and 2020 was $134.29, $149.26 and $68.53, respectively. The total intrinsic value of options exercised during the years ended December 31, 2022, 2021 and 2020 was $154.4 million, $251.9 million and $151.3 million, respectively.
The Company recognizes the fair value of each option as compensation expense on a straight-line basis over the requisite service period, which is generally the vesting period. The options are typically scheduled to vest over four years from the time of grant, subject to the terms of the applicable plan and stock option agreement. The Company records share-based compensation expense only for those awards that are expected to vest and as such, the Company applies an estimated forfeiture rate at the time of grant and adjusts the forfeiture rate estimate quarterly to reflect actual forfeiture activity. In general, in the event of a participant’s voluntary termination of service, unvested options are forfeited as of the date of such termination without any payment to the participant and the cumulative amount of previously recognized expense related to the forfeited options is reversed.
As of December 31, 2022, $23.3 million of total remaining unrecognized compensation cost related to unvested stock options, net of estimated forfeitures, is expected to be recognized over a weighted average period of 2.6 years.
Restricted Stock and Restricted Stock Units
The Company grants restricted stock units (“RSUs”) to Company personnel and non-employee directors. In addition, the Company has issued in the past, and may issue in the future, equity awards to compensate employees of acquired businesses for future services. Equity settled awards granted in connection with acquisitions of businesses may be issued in the form of service-based awards requiring continuing employment with the Company, restricted stock subject to trading restrictions, and performance-based awards, which would vest only if certain specified performance and service conditions are met. The awards issued in connection with acquisitions of businesses are subject to the terms and conditions contained in the applicable award agreements and acquisition documents.
Service-Based Awards
The table below summarizes activity related to the Company’s equity-classified and liability-classified service-based awards for the years ended December 31, 2022, 2021 and 2020:
Equity-Classified
Restricted Stock
Equity-Classified
Equity-Settled
Restricted Stock Units
Liability-Classified
Cash-Settled
Restricted Stock Units
 Number of
Shares
Weighted Average Grant Date
Fair Value Per Share 
Number of
Shares
Weighted Average Grant Date
Fair Value Per Share 
Number of
Shares
Weighted Average Grant Date
Fair Value Per Share 
Unvested service-based awards outstanding as of January 1, 202010 $162.96 759 $122.48 242 $105.40 
Awards granted— $— 294 $204.57 60 $181.77 
Awards modified— $— (1)$122.55 — $— 
Awards vested(1)$63.10 (317)$108.87 (122)$91.39 
Awards forfeited— $— (49)$148.11 (5)$113.94 
Unvested service-based awards outstanding as of December 31, 20209 $167.18 686 $162.15 175 $141.16 
Awards granted— $— 238 $429.41 27 $394.24 
Awards modified— $— — $— — $— 
Awards vested— $— (308)$139.83 (86)$118.05 
Awards forfeited— $— (40)$264.48 (4)$210.26 
Unvested service-based awards outstanding as of December 31, 20219 $167.18 576 $277.38 112 $217.28 
Awards granted— $— 655 $287.13 51 $269.60 
Awards modified— $— (3)$387.74 $220.00 
Awards vested(9)$167.18 (244)$235.96 (56)$184.96 
Awards forfeited— $— (68)$328.81 (11)$260.59 
Unvested service-based awards outstanding as of December 31, 2022 $ 916 $291.19 99 $257.74 
The fair value of vested service-based awards (measured at the vesting date) for the years ended December 31, 2022, 2021 and 2020 was as follows:
 For the Years Ended December 31,
 202220212020
Equity-classified equity-settled
Restricted stock$3,990 $— $101 
Restricted stock units69,510 129,527 60,042 
Liability-classified cash-settled
Restricted stock units16,238 33,947 22,014 
Total fair value of vested service-based awards$89,738 $163,474 $82,157 
As of December 31, 2022, $183.9 million of total remaining unrecognized stock-based compensation costs related to service-based equity-classified RSUs, net of estimated forfeitures, is expected to be recognized over the weighted average remaining requisite service period of 2.8 years.
As of December 31, 2022, $20.0 million of total remaining unrecognized stock-based compensation costs related to service-based liability-classified RSUs, net of estimated forfeitures, is expected to be recognized over the weighted average remaining requisite service period of 2.4 years.
The liability associated with the Company’s service-based liability-classified RSUs as of December 31, 2022 and 2021 was $10.2 million and $31.5 million, respectively, and is classified as Accrued compensation and benefits expenses in the consolidated balance sheets.
Performance-Based Awards
The table below summarizes activity related to the Company’s performance-based awards for the years ended December 31, 2022, 2021 and 2020:
Equity-Classified
Equity-Settled
Restricted Stock
Equity-Classified
Equity-Settled
Restricted Stock Units
 Number of
Shares
Weighted Average Grant Date
Fair Value Per Share 
Number of
Shares
Weighted Average Grant Date
Fair Value Per Share 
Unvested performance-based awards outstanding as of January 1, 20209 $165.87  $ 
Awards granted— $— 31 $210.44 
Awards vested— $— (10)$177.81 
Unvested performance-based awards outstanding as of December 31, 20209 $165.87 21 $227.16 
Awards granted— $— $574.98 
Awards vested— $— (4)$177.81 
Awards forfeited— $— (2)$334.78 
Unvested performance-based awards outstanding as of December 31, 20219 $165.87 23 $339.69 
Awards granted— $— $418.26 
Awards vested $ (9)$238.96 
Awards forfeited $ (5)$377.87 
Unvested performance-based awards outstanding as of December 31, 20229 $165.87 15 $412.60 
As of December 31, 2022, $0.3 million of total remaining unrecognized stock-based compensation costs related to performance-based equity-classified restricted stock is expected to be recognized over the weighted average remaining requisite service period of 0.7 years.
As of December 31, 2022, $3.6 million of total remaining unrecognized stock-based compensation cost related to performance-based equity-classified RSUs is expected to be recognized over the weighted average remaining requisite service period of 2.3 years.
The fair value of vested performance-based awards (measured at the vesting date) for the years ended December 31, 2022, 2021 and 2020 was as follows:
 For the Years Ended December 31,
 202220212020
Equity-classified equity-settled
Restricted stock units$2,914 $2,215 $3,282 
Total fair value of vested performance-based awards$2,914 $2,215 $3,282 

Employee Stock Purchase Plan
The ESPP enables eligible employees to purchase shares of EPAM’s common stock at a discount at the end of each designated offering period, which occurs every six months in April and November. The Company recognizes compensation expense related to shares issued pursuant to the ESPP on a straight-line basis over the six-months offering period. The Company uses the Black-Scholes option pricing model to calculate the fair value of shares issued under the ESPP. The Black-Scholes model relies on a number of key assumptions to calculate estimated fair values. The model incorporated the following weighted average assumptions for the years ended December 31, 2022 and 2021:
For the Years Ended December 31,
20222021
Expected volatility86.8 %23.1 %
Expected term (in years)0.500.50
Risk-free interest rate3.0 %0.1 %
Expected dividends— %— %
Expected volatility is based on the historical volatility of the Company’s stock price. The expected term represents the purchase period for the ESPP. The risk-free rate is based on the U.S. Treasury yield curve for the period equal to the expected term in effect at the time of grant. The Company has not declared or paid any dividends on its common stock and does not anticipate paying any dividends in the foreseeable future.
During the year ended December 31, 2022, the weighted average price per share was $315.60 and the weighted average grant-date fair value per share was $119.76. During the year ended December 31, 2022, the ESPP participants purchased 120 thousand shares of common stock under the ESPP and the Company recognized $13.9 million of stock-based compensation expense related to the ESPP. As of December 31, 2022, total unrecognized stock-based compensation cost related to the ESPP was $4.4 million, which is expected to be recognized over a period of 0.33 years.
During the year ended December 31, 2021, the weighted average price per share was $659.65 and the weighted average grant-date fair value per share was $141.86. As of December 31, 2021, no purchases were made under the ESPP. For the year ended December 31, 2021, the Company recognized $1.2 million of stock-based compensation expense related to the ESPP. As of December 31, 2021, total unrecognized stock-based compensation cost related to the ESPP was $2.3 million, which is expected to be recognized over a period of 0.33 years.
Commitments for Future Equity Awards
In connection with the Company’s acquisitions of businesses as discussed in Note 3 “Acquisitions”, EPAM enters into agreements that contractually commit it to granting equity awards at future dates. The agreements are unique to each acquisition and terms vary to specify the number of future awards to be issued or a monetary value that will be settled with equity awards valued at future stock prices.
As of December 31, 2022, the Company has commitments to grant up to $25.6 million of equity awards with the number of awards to be determined based on future stock prices. There is a service-based vesting requirement associated with these awards and certain of these awards contain performance criteria that will determine the amount of future awards to be issued. These awards are considered granted for accounting purposes. In determining the expense, the Company adjusts the expected settlement based on the probability of achievement of such performance criteria. Related to these awards, the amount of stock-based compensation expense recorded in the consolidated statements of income for the years ended December 31, 2022, 2021 and 2020 was not material.
As of December 31, 2022, the Company has issued 2 thousand performance-based equity-classified RSUs which are not considered granted for accounting purposes as the future vesting conditions have not yet been determined.